Pharmafile Logo
Pharmafocus logo
Advanced Search

opioids

Showing 11 posts of 86 posts found.

shutterstock_138095450

Insys Pharma founder charged over “nationwide conspiracy” to illegally distribute fentanyl

October 27, 2017
Medical Communications, Sales and Marketing Insys Pharma, Subsys, fentanyl, opioid crisis, opioids

John N Kapoor, the 74-year old founder of Insys Pharma, has been legally charged over his involvement in driving a …

News
teva_copy

Teva under investigation over illegal rebate offers to Ontario pharmacies

October 20, 2017
Medical Communications, Sales and Marketing Teva, fentanyl, opioids, oxycodone

Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to …

News
nih_logo

NIH funds research into infant opioid withdrawal syndrome treatment

October 3, 2017
Manufacturing and Production, Research and Development NIH, National Institutes of Health, opioid crisis, opioids, pharma, pharmaceuticals

As the US continues to be plagued by its opioid crisis, which is claiming the lives of more than 100 …

News
fda2outsideweb

Makers of immediate-release opioids must fund training on their use, FDA says

September 29, 2017
Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin

As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …

News
bribe

One in twelve US doctors accepted opioid-related payments from pharma, finds study

August 10, 2017
Medical Communications, Sales and Marketing US, bribe, drugs, life sciences, medicine, opioids, pharma, pharmaceutical

In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …

News
pills-384846_960_720

Research suggests opioid crisis stems from prescription approach

May 18, 2017
Medical Communications, Research and Development opioid crisis, opioids

The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …

News
cdc1

Number of babies born with opioid dependence has tripled in US, says CDC report

August 12, 2016
Medical Communications, Research and Development CDC, addicted, babies, opioid dependence, opioids

A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …

News
doc_writing

US pass new laws to combat opioid epidemic

May 13, 2016
Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse

The US has passed new laws that will seek to combat the current epidemic of opioids across the country. The …

News
shutterstock_4030507

Insys Therapeutics sees revenue from Subsys at $61-$62 million; shares plunge 21%

April 11, 2016
Business Services, Manufacturing and Production, Sales and Marketing Insys Therapeutics, Stock Price, Subsys, opioids, pain drug

Insys Therapeutics Inc (Nasdaq: INSY) stock plunged nearly 21% Monday after the company said sales for its pain drug will …

News
fda_sign_web

FDA announces strongest warnings for opioid pain medications

March 23, 2016
Medical Communications, Research and Development FDA, abuse, addiction, boxed, label, misuse, opioids, public health, restrictions, safety, warnings

The US Food and Drug Administration has announced class-wide safety labelling changes for immediate release (IR) opioid pain medications. The …

News
FDA Hamburg image

FDA publishes guidance on abuse-resistant opioids

January 14, 2013
Manufacturing and Production CDC, FDA, hamburg, opioids

The US Food and Drug Administration has issued draft guidance designed to combat the escalating problem of abuse of prescription …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023